Literature DB >> 2540204

Characterization of a novel isozyme of cGMP-dependent protein kinase from bovine aorta.

L Wolfe1, J D Corbin, S H Francis.   

Abstract

Two isozymic forms of cGMP-dependent protein kinase (designated types I alpha and I beta) were purified to homogeneity from bovine aorta smooth muscle. Type I alpha was apparently the same as the well characterized bovine lung cGMP-dependent protein kinase. Type I beta had a subunit Mr = 80,000 compared with Mr = 78,000 for type I alpha, and both forms were dimeric with similar calculated native Mr (170,000-178,000). Both enzymes contained two cGMP-binding sites per subunit, exhibited similar specificities for the peptide substrates tested, photoaffinity labeled with 8-N3[32P] cAMP, and catalyzed autophosphorylation. Silver-stained peptide maps of types I alpha and I beta were similar but not identical; however, autoradiographs of peptide maps of these enzymes prelabeled by either autophosphorylation or photoaffinity labeling showed clearly different patterns. The amino-terminal sequence of a breakdown product of type I beta could not be aligned confidently with any of the published sequence of bovine lung cGMP-dependent protein kinase. [3H]cGMP dissociation curves for types I alpha and I beta were both biphasic, but the dissociation rate of the slow component of type I beta was faster than the corresponding component of type I alpha. The concentration of cGMP required for half-maximal activation (K alpha) was slightly lower for type I alpha than for type I beta (0.29 and 0.44 microM, respectively), and the two enzymes had similar K alpha values for cAMP (16 and 18 microM, respectively). Types I alpha and I beta exhibited different K alpha values for several cGMP analogs. The abundance of type I beta in specific tissues suggested that it could have an important physiological role.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2540204

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5.

Authors:  Jun Kotera; Kennard A Grimes; Jackie D Corbin; Sharron H Francis
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

2.  Mechanisms associated with cGMP binding and activation of cGMP-dependent protein kinase.

Authors:  Michael E Wall; Sharron H Francis; Jackie D Corbin; Kennard Grimes; Robyn Richie-Jannetta; Jun Kotera; Brian A Macdonald; Rowena R Gibson; Jill Trewhella
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

3.  The role of two novel regulatory sites in the activation of the cGMP-dependent protein kinase from Plasmodium falciparum.

Authors:  Wensheng Deng; Asha Parbhu-Patel; David J Meyer; David A Baker
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

Review 4.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

5.  Design of fluorescence resonance energy transfer (FRET)-based cGMP indicators: a systematic approach.

Authors:  Michael Russwurm; Florian Mullershausen; Andreas Friebe; Ronald Jäger; Corina Russwurm; Doris Koesling
Journal:  Biochem J       Date:  2007-10-01       Impact factor: 3.857

6.  Prolonged treatment of porcine pulmonary artery with nitric oxide decreases cGMP sensitivity and cGMP-dependent protein kinase specific activity.

Authors:  William J Perkins; David O Warner; Keith A Jones
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-24       Impact factor: 5.464

7.  cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.

Authors:  M A Moro; R J Russel; S Cellek; I Lizasoain; Y Su; V M Darley-Usmar; M W Radomski; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

8.  Nitration of tyrosine 247 inhibits protein kinase G-1α activity by attenuating cyclic guanosine monophosphate binding.

Authors:  Saurabh Aggarwal; Christine M Gross; Ruslan Rafikov; Sanjiv Kumar; Jeffrey R Fineman; Britta Ludewig; Danny Jonigk; Stephen M Black
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

9.  Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery.

Authors:  B Bucher; S Ouedraogo; M Tschöpl; D Paya; J C Stoclet
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

10.  Differential patterning of cGMP in vascular smooth muscle cells revealed by single GFP-linked biosensors.

Authors:  Lydia W M Nausch; Jonathan Ledoux; Adrian D Bonev; Mark T Nelson; Wolfgang R Dostmann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.